TickrTrends PM fair value analysis

FDA Authorization Expands Philip Morris’s Zyn Bet, Can It Pay Off?

insidermonkey.com · 2026-09-08

Philip Morris International Inc. (NYSE:PM) has received FDA authorization for 11 nicotine-pouch products, bolstering its position in the fastest-growing nicotine category in the United States.

Read the full story at insidermonkey.com →

Is PM undervalued? See TickrTrends' fair value analysis →